Compare Stocks

Date Range: 

 CeconomyLXRandCoQUIZThe Stanley Gibbons GroupInnovaDerma
SymbolETR:CEC1TSE:LXRLON:QUIZLON:SGILON:IDP
Price Information
Current Price€5.20C$0.13GBX 10.50GBX 2.95GBX 40
52 Week RangeHoldN/ASellN/AN/A
MarketRank™
Overall Score1.10.60.90.51.0
Analysis Score1.00.00.00.00.0
Community Score2.73.02.02.62.5
Dividend Score1.70.01.70.00.0
Ownership Score0.00.00.00.01.7
Earnings & Valuation Score0.00.00.60.00.6
Analyst Ratings
Consensus RecommendationHoldN/ASellN/AN/A
Consensus Price Target€4.96N/AN/AN/AN/A
% Upside from Price Target-4.57% downsideN/AN/AN/AN/A
Trade Information
Market Cap$13.93 millionC$11.60 million£13.04 million£12.59 million£10.95 million
BetaN/AN/AN/AN/AN/A
Average Volume1,597103,619166,080341,696126,377
Sales & Book Value
Annual Revenue$21.01 billionC$13.78 million£72.01 million£11.41 million£12.28 million
Price / Sales0.000.840.181.100.89
Cashflow€8.65 per shareC$0.08 per shareGBX 4.40 per shareGBX 0.59 per shareGBX 1.10 per share
Price / Cash0.601.582.395.0036.36
Book Value€1.69 per shareC$0.03 per shareGBX 18.20 per shareGBX 0.40 per shareGBX 63.30 per share
Price / Book3.083.790.010.070.01
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPS(€0.37)C($0.24)GBX (9.30)GBX (0.90)GBX (7.10)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E Ratio∞∞∞∞∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual Payout€0.32N/AN/AN/AN/A
Dividend Yield6.15%N/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A N/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio553.94%208.00%22.42%1,522.80%0.01%
Current Ratio0.91%3.28%1.87%3.68%1.16%
Quick Ratio0.53%2.30%0.77%0.72%0.19%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees54,029421,7007140
Shares Outstanding2.68 million92.78 million124.23 million426.92 million27.37 million
Next Earnings DateN/A5/12/2021 (Estimated)N/A7/26/2021 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
The Daily Crunch: TechCrunchs parent company sold for $5B, Duolingos origin storyThe Daily Crunch: TechCrunch's parent company sold for $5B, Duolingo's origin story
news.yahoo.com - May 6 at 12:02 AM
Read This Before Selling InnovaDerma PLC (LON:IDP) SharesRead This Before Selling InnovaDerma PLC (LON:IDP) Shares
finance.yahoo.com - May 3 at 9:47 AM
InnovaDerma (LON:IDP) Reaches New 52-Week Low at $35.00InnovaDerma (LON:IDP) Reaches New 52-Week Low at $35.00
americanbankingnews.com - April 30 at 2:18 PM
InnovaDerma PLC - General Meeting and Trading StatementInnovaDerma PLC - General Meeting and Trading Statement
proactiveinvestors.co.uk - April 30 at 9:00 AM
InnovaDerma PLC - Result of Open Offer and General MeetingInnovaDerma PLC - Result of Open Offer and General Meeting
proactiveinvestors.co.uk - April 30 at 9:00 AM
DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sellsDIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells
lse.co.uk - April 19 at 12:37 AM
InnovaDerma PLC (LON:IDP) Insider Mark Michael Ward Buys 171,242 SharesInnovaDerma PLC (LON:IDP) Insider Mark Michael Ward Buys 171,242 Shares
americanbankingnews.com - April 17 at 1:28 AM
InnovaDerma unveils details of open offer proposed in JanuaryInnovaDerma unveils details of open offer proposed in January
proactiveinvestors.co.uk - April 12 at 7:44 AM
InnovaDerma PLC - Interim ResultsInnovaDerma PLC - Interim Results
proactiveinvestors.co.uk - March 31 at 7:10 PM
InnovaDerma confident of quick rise in consumption levels as UK lockdown easesInnovaDerma confident of quick rise in consumption levels as UK lockdown eases
proactiveinvestors.co.uk - March 31 at 4:09 AM
InnovaDerma PLC - Notice of Results, Prospectus and General MeetingInnovaDerma PLC - Notice of Results, Prospectus and General Meeting
proactiveinvestors.co.uk - March 22 at 5:16 PM
InnovaDerma PLC (IDP.L)InnovaDerma PLC (IDP.L)
in.finance.yahoo.com - March 19 at 3:10 PM
Trade Alert: The Independent Non-Executive Director Of InnovaDerma PLC (LON:IDP), Mark Ward, Has Just Spent UK£270k Buying 22% More SharesTrade Alert: The Independent Non-Executive Director Of InnovaDerma PLC (LON:IDP), Mark Ward, Has Just Spent UK£270k Buying 22% More Shares
finance.yahoo.com - November 1 at 5:07 AM
Ishr Msci Eur A Regulatory NewsIshr Msci Eur A Regulatory News
lse.co.uk - October 29 at 11:34 PM
Xtr P Rhod Etc Regulatory NewsXtr P Rhod Etc Regulatory News
lse.co.uk - October 29 at 1:32 PM
UPDATE 1-U.S. offshore energy producers brace for Hurricane Zeta impactUPDATE 1-U.S. offshore energy producers brace for Hurricane Zeta impact
lse.co.uk - October 28 at 1:02 PM
InnovaDerma PLC - Price Monitoring ExtensionInnovaDerma PLC - Price Monitoring Extension
proactiveinvestors.co.uk - October 27 at 2:29 PM
InnovaDerma PLC - Second Price Monitoring ExtnInnovaDerma PLC - Second Price Monitoring Extn
proactiveinvestors.co.uk - October 27 at 2:29 PM
InnovaDerma PLC - Requisition notice and Progress of CEO appointmentInnovaDerma PLC - Requisition notice and Progress of CEO appointment
proactiveinvestors.co.uk - October 23 at 12:22 PM
InnovaDerma says search for new chief executive progressing very wellInnovaDerma says search for new chief executive progressing very well
proactiveinvestors.co.uk - October 23 at 12:22 PM
InnovaDerma PLC - Notice of AGMInnovaDerma PLC - Notice of AGM
proactiveinvestors.co.uk - October 18 at 10:16 PM
Marstons Slams UK Government Pub Restrictions, To Cut 2,150 JobsMarston's Slams UK Government Pub Restrictions, To Cut 2,150 Jobs
lse.co.uk - October 16 at 5:34 PM
InnovaDerma PLC - Appointment of Non-executive DirectorInnovaDerma PLC - Appointment of Non-executive Director
proactiveinvestors.co.uk - October 16 at 12:34 PM
InnovaDerma PLC - Final ResultsInnovaDerma PLC - Final Results
proactiveinvestors.co.uk - September 30 at 9:20 AM
InnovaDerma highlights positive start to new financial yearInnovaDerma highlights positive start to new financial year
proactiveinvestors.co.uk - September 30 at 9:20 AM
DateCompanyBrokerageAction
2/16/2021CeconomyIndependent ResearchSet Price Target
2/10/2021CeconomyKepler Capital MarketsSet Price Target
2/9/2021CeconomyBarclaysSet Price Target
2/9/2021CeconomyBaader BankSet Price Target
12/16/2020CeconomyWarburg ResearchSet Price Target
10/29/2020CeconomyJPMorgan Chase & Co.Set Price Target
8/16/2018LXRandCoCanaccord GenuityDowngrade
6/21/2018LXRandCoCormarkLower Price Target
7/13/2020QUIZPeel HuntReiterated Rating
1/15/2020QUIZPeel HuntReiterated Rating
1/15/2020QUIZShore CapitalReiterated Rating
10/9/2018QUIZBerenberg BankReiterated Rating
7/10/2020InnovaDermaFinnCapReiterated Rating
(Data available from 5/9/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
Comparison Ideas:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.